chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Pain, Palpitations
Clinical narrative: I experienced presyncope at around 6:30am today after receiving the second dose; Sudden ringing in ears; Profuse sweating; Tingling hands; Headache; Low fever; Chills; Body aches; I had slept poorly due to vaccine side effects,; I'd had heart palpitations much of the night after receiving the second dose,; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7533) via an unspecified route of administration in the right arm on 14Apr2021 at 09:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 24Mar2021 at 08:00 as a single dose for COVID-19 immunisation. Previously she also took amoxicillin (MANUFACTURER UNKNOWN) and thiomersal (THIMEROSAL) on unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 14Apr2021, the patient had heart palpitations much of the night after receiving the second dose, along with the other side effects low fever, chills, body aches, and headaches. The patient had slept poorly due to vaccine side effects, and had gotten out of bed early morning to take some paracetamol (TYLENOL) for headache. On 15Apr2021 at 06:30, the patient experienced presyncope, sudden ringing in ears, profuse sweating and tingling hands. The patient did not pass out but felt like it came close. The patient took paracetamol (TYLENOL), while this was happening, and within a few minutes the presyncope episode passed. The patient felt much better after taking the paracetamol (TYLENOL) and sleeping for a few hours. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event except headache. Therapeutic measures were taken as a result of headache which included treatment with paracetamol (TYLENOL). The clinical outcomes of the events heart palpitations, headache, low fever, chills, body aches, presyncope, sudden ringing in ears, profuse sweating, had slept poorly, tingling hands were recovered on 15Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Poor quality sleep, Presyncope, Pyrexia, Tinnitus
Clinical narrative: I experienced presyncope at around 6:30am today after receiving the second dose; Sudden ringing in ears; Profuse sweating; Tingling hands; Headache; Low fever; Chills; Body aches; I had slept poorly due to vaccine side effects,; I'd had heart palpitations much of the night after receiving the second dose,; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7533) via an unspecified route of administration in the right arm on 14Apr2021 at 09:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 24Mar2021 at 08:00 as a single dose for COVID-19 immunisation. Previously she also took amoxicillin (MANUFACTURER UNKNOWN) and thiomersal (THIMEROSAL) on unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 14Apr2021, the patient had heart palpitations much of the night after receiving the second dose, along with the other side effects low fever, chills, body aches, and headaches. The patient had slept poorly due to vaccine side effects, and had gotten out of bed early morning to take some paracetamol (TYLENOL) for headache. On 15Apr2021 at 06:30, the patient experienced presyncope, sudden ringing in ears, profuse sweating and tingling hands. The patient did not pass out but felt like it came close. The patient took paracetamol (TYLENOL), while this was happening, and within a few minutes the presyncope episode passed. The patient felt much better after taking the paracetamol (TYLENOL) and sleeping for a few hours. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event except headache. Therapeutic measures were taken as a result of headache which included treatment with paracetamol (TYLENOL). The clinical outcomes of the events heart palpitations, headache, low fever, chills, body aches, presyncope, sudden ringing in ears, profuse sweating, had slept poorly, tingling hands were recovered on 15Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Sleep disorder
Clinical narrative: This is a spontaneous report from a noncontactable consumer. A 41-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 41, via an unspecified route of administration, right arm, on Apr 11, 2021, at 14:45, single dose, for COVID-19 immunisation. Medical history included migraine headache. The patient did not have any allergies to medications, food, or other products.  Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medication included Excedrin (acetylsalicylic acid/caffeine/paracetamol) taken for unknown indication from unknown date. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 41, via an unspecified route of administration, right arm, on Mar 21, 2021, at 14:45, single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 12, 2021, at 01:00, patient experienced migraine headaches and was unable to sleep. No therapeutic measures taken as result of adverse events. Since the vaccination, patient has not tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of migraine headaches and unable to sleep was resolving. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; This is a spontaneous report from a non-contactable pharmacist. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and nortriptyline (MANUFACTURER UNKNOWN), all from unknown dates  and for unknown indications. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. The patient had no known drug allergies (NKDA). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced fatigue. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event fatigue was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disturbance in attention, Feeling abnormal, Headache, Hyperhidrosis
Clinical narrative: whole body was aching; Sweating; Chills; I felt I had shutter glass all over my body; Strong headache/ headache that did not respond to any medication; Unable to concentrate, focus; Left under arm lymph node very swelled for over 10 days.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included graves. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 03:00, 16 hours after getting the second shot, the patient experienced whole body aching, sweating, chills and felt like the patient had shutter glass all over the body. These symptoms lasted for 4 days. The patient had a strong headache that last for 9 days, unable to concentrate, focus and a headache that did not respond to any medication and left under arm lymph node very swollen for over 10 days. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the event headache and included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events whole body aching, sweating, chills and felt like had shutter glass all over the body was recovered on 05Apr2021, strong headache that did not respond to any medication was recovered on 10Apr2021, left under arm lymph node very swollen was recovered on 11Apr2021 and the outcome of unable to concentrate, focus was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain
Clinical narrative: whole body was aching; Sweating; Chills; I felt I had shutter glass all over my body; Strong headache/ headache that did not respond to any medication; Unable to concentrate, focus; Left under arm lymph node very swelled for over 10 days.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included graves. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 03:00, 16 hours after getting the second shot, the patient experienced whole body aching, sweating, chills and felt like the patient had shutter glass all over the body. These symptoms lasted for 4 days. The patient had a strong headache that last for 9 days, unable to concentrate, focus and a headache that did not respond to any medication and left under arm lymph node very swollen for over 10 days. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the event headache and included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events whole body aching, sweating, chills and felt like had shutter glass all over the body was recovered on 05Apr2021, strong headache that did not respond to any medication was recovered on 10Apr2021, left under arm lymph node very swollen was recovered on 11Apr2021 and the outcome of unable to concentrate, focus was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Weird symmetrical pattern of wine-colored spots around vaccination site. No pain, no itching, flat, smooth surface.; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 07Apr2021 at 15:45(at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included thrombosis leg and had mild allergy to some food products. Concomitant medications were not reported. The patient had mildly known allergy to some food products Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient experienced weird symmetrical pattern of wine colored spots around vaccination site. No pain, no itching, flat, smooth surface. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit, Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the event weird symmetrical pattern of wine-colored spots around vaccination site was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Blood oestrogen, Blood oestrogen increased, Blood prolactin, Blood prolactin increased
Clinical narrative: Prolactin increased; Estrogen increased; This is a spontaneous report from a contactable physician, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 22Feb2021 at 18:00 (at the age of 34-years-old) as a single dose for COVID-19immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, the patient had her prolactin and estrogen increased and reported that her previous levels were normal. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events prolactin increased and estrogen increased were unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Gait inability, Loss of personal independence in daily activities, Muscle spasms, Nausea
Clinical narrative: Severe pain associated with periods; cramping; nausea; Unable to walk due to pain; Unable to walk due to pain or perform any daily tasks; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15(at the age of 30-year-old) as a single dose for COVID-19 immunisation. The medical history of the patient included endometriosis. The concomitant medications of the patient was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 14:00, 3 days after vaccination, the patient experienced severe pain associated with periods, cramping, nausea, unable to walk due to pain or perform any daily tasks. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severe pain associated with periods, cramping, nausea and unable to walk was not recovered at the time of report.    Information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: Chills; Headache; Body aches; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 11:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and supraventricular tachycardia (SVT). The patient had no allergies to food, medications or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN) both taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 at 11:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 14:00 the patient experienced chills, headache, body aches and exhaustion. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, headache, body aches and exhaustion were recovered on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Myalgia, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 40-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP6955), at the age of 40, via an unspecified route of administration, left arm, on Apr 13, 2021, at 09:15, single dose, for COVID-19 immunisation. Medical history included asthma. Concomitant medications included Albuterol (salbutamol) for unknown indication from unknown date and unknown if ongoing. The patient previously received Aspirin and Tussionex for unknown indications and experienced drug allergy. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), via an unspecified route of administration, on an unknown date, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 13, 2021, patient experienced arm soreness, brain fog, muscle aches and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures taken as a result of the arm soreness, brain fog, muscle aches and fatigue included treatment with Tylenol. The outcome of arm soreness, brain fog, muscle aches and fatigue: recovering (at the time of this report). No follow-up attempts needed. No further information expected.
Age: 26.0
Sex: U
Vaccine: COVID19
Symptoms: Headache, Hot flush, Myalgia, Oropharyngeal pain
Clinical narrative: Sore throat; Headache; Hot flashes; Muscle aches; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old patient of an unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EVE 0153) via an unspecified route of administration in the left arm on 13Apr2021 at 10:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, and blood pressure high. Patient had no known allergies. Patient did not receive other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 14:30, the patient experienced sore throat, headache, hot flashes, muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events sore throat, headache, hot flashes, muscle aches was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Urticaria
Clinical narrative: Swollen lymph nodes under right arm; Hives; Headache; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 26Mar2021 at 14:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021, the patient experienced swollen lymph nodes under right arm, hives, headache, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event swollen lymph nodes under right arm, hives, headache, chills and fatigue was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pyrexia, Vomiting
Clinical narrative: Vomiting 3 times in the span of 3 hours; Low grade fever; inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO161) via an unspecified route of administration in the right arm on 14Apr2021 at 09:30(at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included progressive neurodegenerative disorder, primary progressive aphasia. The patient had no known allergies to food, medication or other products. The patient did not receive any other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 29Mar2021 at 12:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 at 17:00, the patient experienced vomiting 3 times in the span of 3 hours and low-grade fever. The clinical outcome of the event low grade fever and vomiting was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: 14 hours after got chilled to the bones& lasted about 4 hours, had on clothes & a hoodie & 2 blankets.; Also had a headache which lasted about 24 hours; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: cw0151) via an unspecified route of administration in the left arm on 13Apr2021 at 18:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, hyperthyroidism, sulfonamide allergy (Bactrum allergy). Concomitant medications included levothyroxine sodium (SYNTHROID), sertraline hydrochloride (ZOLOFT), meloxicam (MOBIC), losartan potassium (COZAAR), molixcan (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6206) via an unspecified route of administration in the left arm on 18Mar2021 at 19:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 10:00, the patient experienced chilled to the bones and lasted about 4 hours, had on clothes and a hoodie and 2 blankets. Also had a headache which lasted about 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chilled to the bones, headache was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 39-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# unknown), at the age of 39, via an unspecified route of administration, on an unknown date, in Apr 2021, at 10:00, single dose, for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included Singulair (montelukast sodium), from unknown date for unknown indication and unknown if ongoing. On an unknown date in Apr 2021, at 19:00 (about 8 hours after first injection), patient was a little nauseous and arm was sore for most of the day. No therapeutic measures taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of nausea and sore arm recovered on an unknown date in Apr 2021. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain
Clinical narrative: Numbness from the left hip to the left leg.; I have a severe pain; This is a spontaneous report from a non-contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown, at the age of 43 years), dose 1 via an unspecified route of administration, administered in Arm Left on 09Apr2021 16:45 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included astemizole (TYRENOL) within 2 weeks of vaccination. The patient reported severe pain and numbness from the left hip to the left leg on 11Apr2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the event. Ovid has not been tested prior to or post vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Blood test, Chills, Emotional distress
Clinical narrative: major illness set in starting with flu symptoms; major illness set in starting with flu symptoms; severe distress; fever; chills; body pain; dangerous elevation Blood Pressure; drastic weight loss; Still sick; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EN6206) via an unspecified route of administration (Age at vaccination 55-year) in Left Arm on 25Mar2021 as dose 2, single for COVID-19 immunization. Medical history included Chronic pain, liver cirrhosis, low oxygen, all from an unknown date and unknown if ongoing. Concomitant medications included morphine; gabapentin; fluoxetine hydrochloride (PROZAC); tamsulosin hydrochloride (FLOWMAX); all taken for an unspecified indication, start and stop date were not reported. Historical Vaccine includes first dose of BNT162B2 (Lot Number: EN6206) administered in left arm on 04Apr2021 at 11:45 AM for COVID-19 immunization; First shot minor issues. No known allergies were reported. No COVID prior vaccination was reported. The patient tested COVID post vaccination. The patient received no other vaccine in fourweeks. On 01Apr2021 at 07:30 PM the patient experienced major illness set in starting with flu symptoms, Ended up with severe distress, fever, chills, body pain, dangerous elevation Blood Pressure, two ER visits, drastic weight loss. Worst parts of the Bible. Still sick but not as severe. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: dangerous elevation on 01Apr2021, blood test for COVID: negative on 10Apr2021, weight: drastic weight loss on 01Apr2021. Therapeutic measures were taken as a result of the adverse events; treatment received with Fluid, migraine meds, CT scan, x-ray, antibiotics. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, Influenza, Pain, Pyrexia, Weight
Clinical narrative: major illness set in starting with flu symptoms; major illness set in starting with flu symptoms; severe distress; fever; chills; body pain; dangerous elevation Blood Pressure; drastic weight loss; Still sick; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EN6206) via an unspecified route of administration (Age at vaccination 55-year) in Left Arm on 25Mar2021 as dose 2, single for COVID-19 immunization. Medical history included Chronic pain, liver cirrhosis, low oxygen, all from an unknown date and unknown if ongoing. Concomitant medications included morphine; gabapentin; fluoxetine hydrochloride (PROZAC); tamsulosin hydrochloride (FLOWMAX); all taken for an unspecified indication, start and stop date were not reported. Historical Vaccine includes first dose of BNT162B2 (Lot Number: EN6206) administered in left arm on 04Apr2021 at 11:45 AM for COVID-19 immunization; First shot minor issues. No known allergies were reported. No COVID prior vaccination was reported. The patient tested COVID post vaccination. The patient received no other vaccine in fourweeks. On 01Apr2021 at 07:30 PM the patient experienced major illness set in starting with flu symptoms, Ended up with severe distress, fever, chills, body pain, dangerous elevation Blood Pressure, two ER visits, drastic weight loss. Worst parts of the Bible. Still sick but not as severe. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: dangerous elevation on 01Apr2021, blood test for COVID: negative on 10Apr2021, weight: drastic weight loss on 01Apr2021. Therapeutic measures were taken as a result of the adverse events; treatment received with Fluid, migraine meds, CT scan, x-ray, antibiotics. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: major illness set in starting with flu symptoms; major illness set in starting with flu symptoms; severe distress; fever; chills; body pain; dangerous elevation Blood Pressure; drastic weight loss; Still sick; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EN6206) via an unspecified route of administration (Age at vaccination 55-year) in Left Arm on 25Mar2021 as dose 2, single for COVID-19 immunization. Medical history included Chronic pain, liver cirrhosis, low oxygen, all from an unknown date and unknown if ongoing. Concomitant medications included morphine; gabapentin; fluoxetine hydrochloride (PROZAC); tamsulosin hydrochloride (FLOWMAX); all taken for an unspecified indication, start and stop date were not reported. Historical Vaccine includes first dose of BNT162B2 (Lot Number: EN6206) administered in left arm on 04Apr2021 at 11:45 AM for COVID-19 immunization; First shot minor issues. No known allergies were reported. No COVID prior vaccination was reported. The patient tested COVID post vaccination. The patient received no other vaccine in fourweeks. On 01Apr2021 at 07:30 PM the patient experienced major illness set in starting with flu symptoms, Ended up with severe distress, fever, chills, body pain, dangerous elevation Blood Pressure, two ER visits, drastic weight loss. Worst parts of the Bible. Still sick but not as severe. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: dangerous elevation on 01Apr2021, blood test for COVID: negative on 10Apr2021, weight: drastic weight loss on 01Apr2021. Therapeutic measures were taken as a result of the adverse events; treatment received with Fluid, migraine meds, CT scan, x-ray, antibiotics. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 43-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER2613), at the age of 43, via an unspecified route of administration, left arm, on Mar 31, 2021, at 09:30, single dose, for COVID-19 immunisation. Medical history: none. The patient has no known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 31, 2021, at 10:30, patient experienced nausea, chills, low fever and fatigue for 72 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures not taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of nausea, chills, low fever and fatigue resolved on Apr 3, 2021 (after the duration of 72 hours). No follow-up attempts possible. No further information expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Upper-airway cough syndrome
Clinical narrative: Experience tired/achy and postnasal drip; Experience tired/achy and postnasal drip; Experience tired/achy and postnasal drip; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 the patient experienced tired/achy and postnasal drip. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events experienced tired/achy and postnasal drip was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Left deltoid soreness, mild to moderate, resolving with exercise; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 428068) via an unspecified route of administration in the arm left on 14Apr2021 at 13:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 16:00, the patient experienced Left deltoid soreness, mild to moderate, resolving with exercise. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event left deltoid soreness, mild to moderate, resolving with exercise was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath since first vaccine; This is a spontaneous report from a contactable consumer (patient). A 39-years-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date of 2021 as dose 1, single (at the age of 39-years-old) for COVID-19 immunisation. Medical history included Magnetic Resonance Imaging (MRI) dye allergy from an unknown date and unknown if ongoing. Patient had no other vaccine in four weeks. Patient had no other medications/ concomitant medications in two weeks. Patient was not diagnosed with COVID-19 prior to vaccination and on an unspecified date of 2021, patient had been tested for COVID-19, post vaccination, by nasal swab test and result was negative. On 18Mar2021, patient experienced shortness of breath since first vaccine. Patient had doctor or other healthcare professional office/clinic and emergency room/department or urgent care visit for the event. Therapeutic measures were taken as a result of shortness of breath since first vaccine and treatment included steroid. The outcome of the event was not recovered.  No follow up attempts are possible; Information about lot/batch number cannot be requested. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Nausea
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 39-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0158), at the age of 39, via an unspecified route of administration, left arm, on Apr 8, 2021, at 15:00, single dose, for COVID-19 immunisation. Medical history included latex allergy. The patient previously received Celexa (citalopram hydrobromide), for an unknown indication from an unspecified date; and experienced drug allergy. Concomitant medications not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP7534) via an unspecified route of administration, left arm, on Mar 17, 2021, at 11:30, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 9, 2021, at 04:00, patient experienced flu-like symptoms (nausea; headaches; fatigue) 12 hours after the shot, which lasted 4 days. The fatigue lasted 7 days after shot. No therapeutic measures taken as a result of reported events. The outcome of flu-like symptoms 12 hours after shot (nausea and headaches) recovered on Apr 12, 2021; while fatigue: recovering (at the time of this report). No follow-up attempts possible. No further information expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Dizziness, Headache, Musculoskeletal stiffness, Nasal congestion
Clinical narrative: Stuffy nose; Sore throat; Headache; Elevated temperature; Injection site was sore; Neck was stiff; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN)via an unspecified route of administration on an unknown date(at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, generalized anxiety disorder(GAD), conversion disorder, 4 concussion, hypermobility and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN) , fluoxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and omeprazole magnesium (OMEPRAL); all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 07:00, the patient experienced injection site was sore, neck was stiff and dizziness. On 15Apr2021, the patient experienced stuffy nose, sore throat, headache and elevated temperature. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site was sore, neck was stiff dizziness, stuffy nose, sore throat, headache and elevated temperature were resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Vaccination site pain
Clinical narrative: Stuffy nose; Sore throat; Headache; Elevated temperature; Injection site was sore; Neck was stiff; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN)via an unspecified route of administration on an unknown date(at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, generalized anxiety disorder(GAD), conversion disorder, 4 concussion, hypermobility and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN) , fluoxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and omeprazole magnesium (OMEPRAL); all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 07:00, the patient experienced injection site was sore, neck was stiff and dizziness. On 15Apr2021, the patient experienced stuffy nose, sore throat, headache and elevated temperature. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site was sore, neck was stiff dizziness, stuffy nose, sore throat, headache and elevated temperature were resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected